Search Results for: 渶 rbh443.top Ͽ渶 ¶θ ̻縮 ͳݰ渶 Ʈ 渶 ߱ ߰  – Page 2

Employers, Unions, & Insurers

PBMs administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurers, and labor unions, as well as through public programs such as Medicare and Medicaid. A common thread connecting all programs
Read More »

Drug Abuse Prevention

PCMA supports the creation of “Safe Pharmacies” in Medicare Part D for Controlled Prescription Drugs. The creation of “Safe Pharmacies,” or a “Lock-In” program in Part D for controlled substances, will allow Part D plans to require at-risk beneficiaries to
Read More »

Value & Outcomes-Based Contracting

PBMs and payers are committed to the affordability and sustainability of the healthcare system and recognize the importance of aligning reimbursement around value instead of volume. Traditionally, risk-sharing agreements between payers and drug manufacturers have not been tied to the
Read More »

Fraud, Waste, & Abuse

PBMs employ a variety of state-of-the-art techniques when working with pharmacies and other stakeholders to combat fraud, waste, and abuse. Vigilance against fraud is paramount to ensure that scarce health care resources are used for legitimate purposes. According to PCMA-sponsored
Read More »

Drug Coupons & Assistance Programs

Drug companies rely on financial subsidy programs to increase product uptake among insured patients. Unlike means-tested patient assistance programs, which assist uninsured or indigent populations, copay assistance and free drug programs target patients who are already covered by insurance plans.
Read More »

The Hill’s Top Lobbyists 2021

Street played an outsized role in this year’s policy debates, working behind the scenes to reshape the COVID-19 relief package, bipartisan infrastructure bill and Democrats’ climate and social spending plan.

Read More »

Pharmacy Contracting & Reimbursement

PBMs contract with pharmacies on behalf of health plans and employers to serve patients by building networks of preferred pharmacies. As part of the negotiations to become a preferred network provider, pharmacies and PBMs negotiate contract types, payment rates for
Read More »

Drug Cost Management

The management of high cost drugs is receiving increased attention from patients, providers, payers, and policymakers due to ongoing drug price increases and the aggregate impact on health care costs. PBMs are responsible for creating novel solutions to improve the quality
Read More »